These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 9442070)
1. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. Mattu TS; Pleass RJ; Willis AC; Kilian M; Wormald MR; Lellouch AC; Rudd PM; Woof JM; Dwek RA J Biol Chem; 1998 Jan; 273(4):2260-72. PubMed ID: 9442070 [TBL] [Abstract][Full Text] [Related]
2. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. Boehm MK; Woof JM; Kerr MA; Perkins SJ J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707 [TBL] [Abstract][Full Text] [Related]
3. The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease. Hui GK; Wright DW; Vennard OL; Rayner LE; Pang M; Yeo SC; Gor J; Molyneux K; Barratt J; Perkins SJ Biochem J; 2015 Oct; 471(2):167-85. PubMed ID: 26268558 [TBL] [Abstract][Full Text] [Related]
5. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc. Anumula KR J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540 [TBL] [Abstract][Full Text] [Related]
6. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885 [TBL] [Abstract][Full Text] [Related]
7. FcαRI binding at the IgA1 C Posgai MT; Tonddast-Navaei S; Jayasinghe M; Ibrahim GM; Stan G; Herr AB Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8882-E8891. PubMed ID: 30181292 [TBL] [Abstract][Full Text] [Related]
8. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells. Hills AE; Patel A; Boyd P; James DC Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148 [TBL] [Abstract][Full Text] [Related]
9. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731 [TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Field MC; Amatayakul-Chantler S; Rademacher TW; Rudd PM; Dwek RA Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):261-75. PubMed ID: 8166649 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity. Lardinois OM; Deterding LJ; Hess JJ; Poulton CJ; Henderson CD; Jennette JC; Nachman PH; Falk RJ PLoS One; 2019; 14(2):e0213215. PubMed ID: 30818380 [TBL] [Abstract][Full Text] [Related]
13. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Herr AB; Ballister ER; Bjorkman PJ Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205 [TBL] [Abstract][Full Text] [Related]
14. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1. Carayannopoulos L; Hexham JM; Capra JD J Exp Med; 1996 Apr; 183(4):1579-86. PubMed ID: 8666916 [TBL] [Abstract][Full Text] [Related]
15. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing. Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555 [TBL] [Abstract][Full Text] [Related]
16. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438 [TBL] [Abstract][Full Text] [Related]
17. Effects of limited reduction on disulfide bonds in human IgA1 and IgA1 fragments. Biewenga J; van Run PE Mol Immunol; 1992 Mar; 29(3):327-34. PubMed ID: 1557043 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930 [TBL] [Abstract][Full Text] [Related]
19. Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors. Blundell PA; Le NPL; Allen J; Watanabe Y; Pleass RJ J Biol Chem; 2017 Aug; 292(31):12994-13007. PubMed ID: 28620050 [TBL] [Abstract][Full Text] [Related]